Search clinical trials for: Benign prostatic obstruction (BPO)

Total 9554 results

Allergan

Completed

Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

France, Poland, Korea, Republic of, Canada, United States, Germany, Philippines, Czechia
Intermountain Health Care, Inc.
NuView Diagnostics

Unknown

Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones. (VPAC)

Prostate Cancer | Kidney Stones | Benign Prostatic Hypertrophy | Bladder Stones

United States
University of Virginia
Siemens Medical Solutions

Unknown

Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Hyperplasia | Male Urogenital Diseases | Prostatic Hypertrophy | Benign Prostatic Hyperplasia (BPH) | Genital Diseases, Male | Lower Urinary Tract Symptoms (LUTS) | Prostatism

United States
Stanford University

Completed

Prospective Evaluation of Winged Biliary Stent Patency in Patients With Benign Biliary Obstruction

Biliary Stricture

United States
Medical University of Lodz

Completed

Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy

Benign Prostatic Hyperplasia

Poland
Astellas Pharma Inc
Astellas Pharma Singapore Pte. Ltd.

Completed

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Overactive Bladder

Japan, Korea, Republic of
JUNGNAM KWON

Completed

Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study

Benign Prostatic Hyperplasia | Lower Urinary Tract Symptom | BPH | Benign Prostatic Hypertrophy

Korea, Republic of
Eli Lilly and Company

Terminated

A Study in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Germany, France, Australia, Greece, Canada, Russian Federation, Italy
GlaxoSmithKline

Completed

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Korea, Republic of, China, Japan, Taiwan
NeoTract, Inc.

Completed

UroLift System TOlerability and ReCovery When Administering Local Anesthesia (LOCAL)

Benign Prostatic Hyperplasia

United States
Indiana Kidney Stone Institute
Richard Wolf Medical Instruments Corporation (RWMIC)

Completed

Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures

Benign Prostatic Hypertrophy Requiring Surgical Intervention

United States
I.M. Sechenov First Moscow State Medical University

Completed

Benign Prostatic Hyperplasia and Ischemic Heart DIsease

Benign Prostatic Hyperplasia (BPH) | Lower Urinary Tract Symptoms (LUTS) | Ischaemic Heart Disease (IHD)
NeoTract, Inc.

Completed

Study of Median Lobe Prostatic UroLift Procedure

Benign Prostatic Hyperplasia (BPH)
PROCEPT BioRobotics

Completed

French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

Benign Prostatic Hyperplasia (BPH)

France
University of Bari
Gaetano de Rienzo; Pasquale Ditonno; Francesco Di Modugno; Michele Battaglia; Giuseppe... and other collaborators

Unknown

Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques

Benign Prostatic Hyperplasia (BPH)

Italy
Zenflow, Inc.

Unknown

The Zenflow Spring System Feasibility and Safety Study (ZEST)

Benign Prostatic Hyperplasia

Bulgaria, New Zealand
Taha Uçar

Unknown

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy

Pain | Lower Urinary Tract Symptoms | Bladder Cancer | Benign Prostate Hyperplasia | Hematuria

Turkey
University of Arkansas

Withdrawn

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Multiple Myeloma

United States
Yonsei University

Unknown

Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient

Klatskin Tumor | Biliary Obstructive Disease Such as Choledocholithiasis | Benign Biliary Stricture | Peri-ampullary Cancer | Bile Duct Cancer Resectable

Korea, Republic of
Materia Medica Holding

Completed

Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression

Benign Prostatic Hyperplasia

Russian Federation, Ukraine
Sophiris Bio Corp

Completed

Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia (TRIUMPH-1)

Benign Prostatic Hyperplasia

Canada
Changhai Hospital
Shanghai Zhongshan Hospital; RenJi Hospital; Huashan Hospital; Southwest Hospital... and other collaborators

Unknown

Prostatic Obstruction Investigation Team Multicenter Study (POInT)

Lower Urinary Tract Symptoms

China
South Florida Medical Imaging, PA

Terminated

Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams

Prostatic Hyperplasia

United States
Siami, Paul F., M.D.
GlaxoSmithKline

Completed

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Vantia Ltd

Completed

Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC)

Nocturia

United States
VA Office of Research and Development
Merck Sharp & Dohme LLC; Endo Pharmaceuticals

Completed

5-Alpha Reductase and Anabolic Effects of Testosterone

Sarcopenia | Muscle Atrophy | Male Hypogonadism | Benign Prostate Hypertrophy

United States
National Institute of Diabetes and Digestive and...
George Washington University

Completed

Medical Therapy of Prostatic Symptoms (MTOPS)

Prostatic Hyperplasia | Prostatic Hypertrophy, Benign

United States
GlaxoSmithKline

Completed

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Prostatic Hyperplasia

Japan
Johns Hopkins University

Completed

Ultrasound-Guided Photoselective Vaporization of the Prostate

Benign Prostatic Hyperplasia

United States
NeoTract, Inc.

Completed

The Safety and Effectiveness of UroLift: LIFT Pivotal Study (LIFT)

Benign Prostatic Hyperplasia

United States, Australia, Canada
Merck Sharp & Dohme LLC

Terminated

Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)

Benign Prostatic Hyperplasia
GlaxoSmithKline

Terminated

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia (FDC114785)

Prostatic Hyperplasia

Vietnam
GlaxoSmithKline

Completed

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (CONDUCT)

Prostatic Hyperplasia

Italy, Spain, United Kingdom, Netherlands, Greece, Romania, France, Germany
IMBiotechnologies Ltd.

Completed

Safety and Efficacy of OCL 503 in Prostate Artery Embolization

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Canada
Light Sciences Oncology
Mundipharma Research Limited

Completed

A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
AEterna Zentaris

Terminated

Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

Benign Prostatic Hypertrophy

United States, Canada, Bulgaria, Germany
Health Ever Bio-Tech Co., Ltd.

Completed

Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS_LUTS)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Taiwan
Kantonsspital Graubuenden

Completed

Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis

Lymph Node Disease | Radiotherapy Side Effect | Prostatic Neoplasms Benign

Switzerland
Boston Scientific Corporation

Completed

PROMUS Element Plus US Post-Approval Study

Coronary Artery Disease

United States
Mansoura University

Unknown

Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT (EPPROSTATECT)

Prostatic Hyperplasia | Prostate Disease | BPH With Urinary Obstruction | Prostate Obstruction | Ejaculation Abnormal

Egypt
IRCCS San Raffaele

Unknown

Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands (ExpHo)

Benign Prostatic Hyperplasia

Italy
Brooklyn Urology Research Group
American Medical Systems; Richard Wolf Medical Instruments Corporation (RWMIC)

Completed

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

United States
Fundacion Miguel Servet

Completed

Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Transurethral Resection of Prostate | Artery Embolization

Spain
Olympus Corporation of the Americas
Loma Linda University; VA Greater Los Angeles Healthcare System

Terminated

Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode

Benign Prostatic Hyperplasia

United States
Changhai Hospital

Unknown

Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship

Prostatic Neoplasms | Benign Prostatic Hyperplasia | Digital Rectal Examination

China
St. Louis University

Withdrawn

Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Urinary Incontinence, Urge | Nocturia | Incontinence, Urinary | Urinary Frequency/Urgency

United States
JW Pharmaceutical

Completed

Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System (CV)

Benign Prostatic Hyperplasia

Korea, Republic of
Rennes University Hospital

Completed

Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers (CANARI)

Benign Prostate Hyperplasia

France
St. Joseph's Healthcare Hamilton
Ontario Ministry of Health and Long Term Care

Completed

PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate (PVP)

Benign Prostatic Hyperplasia

Canada
Cairo University

Completed

Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Ultrasonography | Male | Botulinum Toxins, Type A | Injection; Complications, Infection

Egypt

Search clinical trials for: Benign prostatic obstruction (BPO)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations